04:20 PM EDT, 09/16/2025 (MT Newswires) -- Nello Mainolfi, Director, Chief Executive Officer, on September 16, 2025, sold 30,000 shares in Kymera Therapeutics ( KYMR ) for $1,470,000. Following the Form 4 filing with the SEC, Mainolfi has control over a total of 660,482 common shares of the company, with 660,482 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1815442/000119312525204997/xslF345X05/ownership.xml